GURU.Markets stock price, segment price, and overall market index valuation
The company's share price DarioHealth Corp.
DarioHealth is a digital therapeutic platform for managing chronic conditions such as diabetes and hypertension. Its stock price reflects the growth of the digital health market, but also its intense competition and long road to profitability.
Share prices of companies in the market segment - Telemed
DarioHealth is a digital health company that provides a platform for managing chronic conditions such as diabetes and hypertension. We've categorized it as "Telemedicine." The chart below shows how the digital health sector is rated by the market.
Broad Market Index - GURU.Markets
DarioHealth is a digital therapeutics company that provides a platform for managing chronic conditions such as diabetes and hypertension. As a pioneer, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Dario's performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
DRIO - Daily change in the company's share price DarioHealth Corp.
For DarioHealth Corp., a digital therapeutics company, daily volatility reflects sensitivity to user growth and contracts with employers and insurance companies. This metric is an indicator of the state of the digital health market.
Daily change in the price of a set of shares in a market segment - Telemed
DarioHealth Corp. is a digital health company. This chart highlights the sector's high volatility. Comparing it to DRIO, which focuses on chronic disease treatment, helps us understand how its business model is ahead of industry trends.
Daily change in the price of a broad market stock, index - GURU.Markets
DarioHealth is a digital health company offering a platform for managing chronic conditions such as diabetes. Its stock price reflects the pace of digital adoption in healthcare. Its volatility is part of the overall picture of medical innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization DarioHealth Corp.
For DarioHealth Corp., year-over-year performance is a story about its digital platform for chronic disease management. Its 12-month market cap growth reflects its success in securing contracts with employers and insurance companies, which offer its app to their clients for managing diabetes, hypertension, and other conditions.
Annual dynamics of market capitalization of the market segment - Telemed
DarioHealth Corp. is a digital therapeutics company providing a chronic disease management platform. This chart illustrates how its innovative model, competition, and reliance on contracts with employers and insurers are impacting its performance in the telemedicine sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
DarioHealth, a digital health company, is betting on healthcare transformation. Its performance relative to the market reflects how quickly its chronic disease management platform is being adopted by insurers and employers. It's a growth story where the speed of innovation is crucial.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization DarioHealth Corp.
DarioHealth is a digital health company offering a chronic disease management platform. Its monthly growth is driven by user growth and contracts with employers and insurance companies. Quarterly revenue reports are key.
Monthly dynamics of market capitalization of the market segment - Telemed
DarioHealth is a digital therapeutics company that provides personalized solutions for managing chronic conditions such as diabetes and hypertension through a mobile app. The graph below shows the overall dynamics of the telemedicine sector, which is growing on the wave of a desire for more convenient and proactive health management.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Digital health stocks are growth bets, but highly sensitive to market risk. The chart below illustrates this sentiment. Is DarioHealth moving at a higher amplitude, reflecting both faith in the future of telemedicine and broader market fluctuations?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization DarioHealth Corp.
DarioHealth, a digital therapeutics company offering a platform for managing chronic conditions such as diabetes, is responding to healthcare news. Its weekly stock price reflects contract signings with employers and insurance companies, as well as user engagement data.
Weekly dynamics of market capitalization of the market segment - Telemed
DarioHealth, like other companies in the digital healthcare sector, is riding the wave of the overall trend toward healthcare digitalization. Demand for telemedicine and chronic disease management is a tailwind for the entire sector. The chart will show how DRIO competes in this niche compared to the industry average.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
DarioHealth Corp., as a healthcare company, can demonstrate defensive qualities by moving out of sync with the broader market. Demand for its digital health solutions is less dependent on economic cycles. The chart will help assess whether DRIO truly is a safe haven during periods of general market turbulence.
Market capitalization of the company, segment and market as a whole
DRIO - Market capitalization of the company DarioHealth Corp.
DarioHealth's market capitalization is a story about digital chronic disease management. The company provides a platform for patients with diabetes and hypertension. Its valuation chart reflects how investors assess its ability to attract users and compete in the crowded digital health market.
DRIO - Share of the company's market capitalization DarioHealth Corp. within the market segment - Telemed
DarioHealth is a digital therapeutics company providing a platform for managing chronic conditions such as diabetes and hypertension. Its share of the telemedicine sector reflects its holistic approach. The chart shows how its B2B model is in demand by employers and insurers to reduce costs.
Market capitalization of the market segment - Telemed
DarioHealth is a platform for managing chronic conditions such as diabetes and hypertension using a smartphone. The graph below shows the market capitalization of the telemedicine sector. Its growth reflects the trend toward digitalization of healthcare and patient engagement.
Market capitalization of all companies included in a broad market index - GURU.Markets
DarioHealth is a digital therapeutics company that provides a platform for managing chronic conditions such as diabetes and hypertension. Its market capitalization reflects its focus on digital healthcare. The chart below shows the weighting of companies changing the approach to treatment.
Book value capitalization of the company, segment and market as a whole
DRIO - Book value capitalization of the company DarioHealth Corp.
DarioHealth is built on a digital therapeutics platform. The company's book value reflects its investments in developing smart glucometers and a mobile app that helps people manage chronic conditions such as diabetes and hypertension. The chart below shows how the company built its technological and informational foundation.
DRIO - Share of the company's book capitalization DarioHealth Corp. within the market segment - Telemed
DarioHealth, a telemedicine company, has minimal physical assets (offices and warehouses with devices). The S_BCap_Seg graph shows its "asset-light" model, where value is created through an online platform.
Market segment balance sheet capitalization - Telemed
DarioHealth provides a digital therapeutic platform for chronic disease management. Its business is software and data, not clinics. The book value chart shows how "lightweight" its model is, with its key assets being its technology and user base.
Book value of all companies included in the broad market index - GURU.Markets
DarioHealth's assets comprise a digital platform for chronic disease management. The company's book value reflects its inventory of connected devices (glucometers, blood pressure monitors) and a powerful IT infrastructure for data analysis and coaching. This provides the material basis for creating a comprehensive patient support system.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - DarioHealth Corp.
DarioHealth is a digital therapeutics company offering a platform for managing chronic conditions such as diabetes. Its value lies in its app, data, and user base. Its market capitalization reflects its bet on the future of digital medicine and its B2B2C model.
Market to book capitalization ratio in a market segment - Telemed
DarioHealth is a digital therapeutics company offering a chronic disease management platform. Its value lies in its technology and data. The chart shows the market premium for its platform compared to its minimal tangible assets.
Market to book capitalization ratio for the market as a whole
DarioHealth is a digital healthcare company offering a platform for managing chronic diseases such as diabetes. The company's value lies in its technology platform and data. The chart illustrates how investors highly value the potential of digital healthcare, creating a large gap between its market value and book value.
Debts of the company, segment and market as a whole
DRIO - Company debts DarioHealth Corp.
DarioHealth, a digital health company, is using debt to scale its platform and grow. This chart shows how the company is investing in marketing to attract users with chronic conditions (diabetes, hypertension) and expanding its offerings to corporate clients and insurance companies.
Market segment debts - Telemed
DarioHealth is a digital therapeutics company offering a platform for managing chronic conditions like diabetes. This sector requires ongoing investment in technology and marketing to attract users and corporate clients. This chart shows how they fund their growth.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio DarioHealth Corp.
DarioHealth offers a digital platform for managing chronic conditions such as diabetes. This chart shows how the company is funding its growth in the digital health sector. Debt can be used for marketing to attract users and developing new features, a typical but risky strategy for tech startups.
Market segment debt to market segment book capitalization - Telemed
DarioHealth is a digital health company offering chronic disease management solutions. This chart for the telehealth sector shows how companies finance their growth and marketing to attract users and corporate clients. It helps assess the sustainability of the company's business model.
Debt to book value of all companies in the market
DarioHealth is a digital therapeutics company offering a platform for managing chronic diseases such as diabetes. Their business is at the intersection of technology and healthcare. The debt-to-book ratio chart shows how aggressively the healthcare sector is investing in digital solutions to improve treatment efficiency.
P/E of the company, segment and market as a whole
P/E - DarioHealth Corp.
DarioHealth is a digital therapeutics company that offers a platform for managing chronic conditions such as diabetes and hypertension. This chart reflects the future of healthcare. Its growth reflects confidence that its integrated approach will help patients better manage their conditions and employers reduce costs.
P/E of the market segment - Telemed
DarioHealth Corp. represents the digital health sector. This chart shows the average price-to-earnings ratio for this fast-growing industry. A company's price-to-earnings ratio (P/E) is higher than average, indicating that investors view its chronic disease management platform as particularly promising and poised to capture a significant share of the market.
P/E of the market as a whole
DarioHealth is a digital health company that offers a platform for managing chronic conditions such as diabetes and hypertension. This chart reflects trends in the healthcare sector. The company's valuation depends on its ability to secure contracts with employers and insurance companies, demonstrating that its platform helps reduce healthcare costs and improve patient outcomes.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company DarioHealth Corp.
DarioHealth is a digital therapeutics company offering a platform for managing chronic conditions such as diabetes and hypertension. The graph shows future revenue expectations, which depend on user growth and contracts with employers and insurance companies.
Future (projected) P/E of the market segment - Telemed
DarioHealth is a digital therapeutics company that provides personalized solutions for people with chronic conditions such as diabetes and hypertension. This chart shows how its future revenue expectations compare to the industry average. Does the market believe in its data-driven health management model?
Future (projected) P/E of the market as a whole
DarioHealth is a digital healthcare company offering a platform for managing chronic conditions such as diabetes and hypertension. The company's growth is fueled by the trend toward telemedicine and digital health. This structural shift makes it less dependent on short-term economic cycles.
Profit of the company, segment and market as a whole
Company profit DarioHealth Corp.
DarioHealth Corp. offers an integrated digital therapeutic platform for managing chronic conditions such as diabetes, hypertension, and mental health. The company's revenue depends on the number of users and contracts with employers and insurance companies. This chart shows how the digital health trend is impacting its financial results.
Profit of companies in the market segment - Telemed
DarioHealth Corp. is a digital therapeutics company providing personalized solutions for people with chronic conditions such as diabetes and hypertension. This chart reflects the profitability of the telemedicine sector. The company's platform helps patients manage their health. Its growth is driven by the trend toward digitalization of healthcare.
Overall market profit
DarioHealth Corp. offers a digital platform for managing chronic conditions such as diabetes and hypertension. Demand for digital health solutions is growing due to their effectiveness and convenience. This long-term trend makes DarioHealth's business less dependent on short-term economic cycles, as illustrated by this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company DarioHealth Corp.
DarioHealth is a digital therapeutics company providing a platform for managing chronic conditions such as diabetes and hypertension. This chart reflects analysts' expectations for future revenue, which hinge on user growth and contracts with employers and insurance companies. It demonstrates the market's confidence in the future of digital medicine.
Future (predicted) profit of companies in the market segment - Telemed
DarioHealth Corp. offers an integrated digital therapeutic platform for managing chronic conditions such as diabetes and hypertension. This chart shows profitability forecasts for the telemedicine sector. It reflects expectations for the growth of digital health and personalized patient care.
Future (predicted) profit of the market as a whole
DarioHealth is a digital therapeutic platform for chronic diseases. The implementation of such technologies depends on the budgets of employers and insurance companies. The forecast for overall market revenue growth indicates that corporate clients will have the funds to invest in employee health, which is a driver for DarioHealth.
P/S of the company, segment and market as a whole
P/S - DarioHealth Corp.
DarioHealth Corp. offers a digital therapeutic platform for managing chronic diseases such as diabetes. Revenue is generated through a subscription model. The price-to-sales ratio for a digital health company like this reflects how investors view its user base growth and technology.
P/S market segment - Telemed
DarioHealth Corp. provides a digital therapeutic platform for people with chronic conditions such as diabetes and hypertension. They combine devices, an app, and coaching. This chart shows how investors view their B2B2C model (selling through employers and insurers) and their position in the growing digital health market.
P/S of the market as a whole
DarioHealth provides a digital platform for managing chronic conditions such as diabetes and hypertension. Revenue is generated through a subscription model. This chart illustrates the average revenue estimate, which helps understand the premium the market is willing to pay for revenue in the growing digital health sector.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company DarioHealth Corp.
DarioHealth is a digital therapeutics company offering a platform for managing chronic conditions such as diabetes and hypertension. This chart reflects investor expectations for future subscription revenue growth, which depends on its ability to secure contracts with employers and insurance companies.
Future (projected) P/S of the market segment - Telemed
DarioHealth Corp. is a digital therapeutics company offering a platform for managing chronic conditions such as diabetes and hypertension. This chart shows how the market estimates its future subscription revenue. It compares it to other telemedicine companies, reflecting the growth of the digital health market and its integrated approach.
Future (projected) P/S of the market as a whole
DarioHealth is a digital therapeutics company that offers a platform for managing chronic conditions such as diabetes and hypertension. This chart shows overall market revenue expectations, and DRIO illustrates how digital technologies are changing healthcare, making it more personalized and accessible.
Sales of the company, segment and market as a whole
Company sales DarioHealth Corp.
DarioHealth Corp. provides an integrated digital therapeutic platform for managing chronic conditions such as diabetes, hypertension, and mental health. Its revenue, reflected in this chart, is generated through subscriptions to its B2B solutions, which companies offer to their employees as benefits.
Sales of companies in the market segment - Telemed
DarioHealth is a digital therapeutics company offering chronic disease management solutions. This chart segments its revenue, showing revenue from device sales and subscriptions to its digital platform. This reflects its transition to a recurring revenue model.
Overall market sales
DarioHealth Corp. provides a digital therapeutic platform for chronic disease management. The company's growth is driven by the digitalization of healthcare. This long-term trend is more important than the short-term economic fluctuations reflected in this chart, as it addresses rising healthcare costs.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company DarioHealth Corp.
DarioHealth is a digital therapeutics company offering a platform for managing chronic conditions such as diabetes and hypertension. Its revenue forecast depends on the number of users and contracts with employers and insurance companies. This chart shows the expected growth of the digital health market.
Future (projected) sales of companies in the market segment - Telemed
DarioHealth Corp. offers a digital therapeutic platform for managing chronic conditions such as diabetes and hypertension. This chart shows projected revenue for the entire telemedicine sector. It reflects the growing trend toward using digital health monitoring tools, a key driver of DarioHealth's user growth.
Future (projected) sales of the market as a whole
DarioHealth is a digital therapeutics company offering solutions for managing chronic diseases such as diabetes. Demand for its services is driven by the adoption of digital health by insurers and employers. This dynamic of overall economic expectations is impacting healthcare budgets and companies' willingness to invest in employee wellness programs.
Marginality of the company, segment and market as a whole
Company marginality DarioHealth Corp.
DarioHealth is a digital therapeutics company providing a platform for managing chronic conditions such as diabetes and hypertension. This chart illustrates the economics of the subscription model in healthcare. Its profitability depends on the number of users and contracts with employers and insurance companies.
Market segment marginality - Telemed
DarioHealth Corp. offers an integrated digital therapeutic platform for managing chronic conditions such as diabetes and hypertension. This chart reflects the average profitability in the telemedicine sector. It helps assess how effectively DarioHealth monetizes its platform and competes in the rapidly growing digital health market.
Market marginality as a whole
DarioHealth Corp. offers a digital platform for managing chronic conditions such as diabetes and hypertension. The company operates in the rapidly growing digital healthcare sector. This overall profitability chart illustrates the pressure on traditional healthcare systems, driving demand for more effective and personalized solutions from DarioHealth.
Employees in the company, segment and market as a whole
Number of employees in the company DarioHealth Corp.
DarioHealth is a digital health company providing a platform for managing chronic conditions such as diabetes. The growth of its team of developers, coaches, and sales specialists reflects the expansion of its platform and the growing number of users and corporate clients.
Share of the company's employees DarioHealth Corp. within the market segment - Telemed
DarioHealth Corp. offers an integrated digital therapeutic platform for managing chronic conditions such as diabetes and hypertension. This chart illustrates its role in digital health. It reflects the proportion of developers, nutritionists, health coaches, and data analysts working on personalized patient support that Dario brings together.
Number of employees in the market segment - Telemed
DarioHealth Corp. provides a digital therapeutic platform for managing chronic conditions such as diabetes and hypertension. This chart reflects employment in the telemedicine sector. Rapid growth in this area reflects the shift toward proactive and personalized health management using mobile technologies.
Number of employees in the market as a whole
DarioHealth Corp. is a digital therapeutics company offering solutions for people with chronic conditions such as diabetes. Digital healthcare allows for better condition management and reduced costs. This graph illustrates overall employment, and these companies are at the intersection of IT and medicine, creating a new market for services.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company DarioHealth Corp. (DRIO)
DarioHealth is a digital healthcare company. Its value lies in its IT platform, which helps patients manage chronic conditions. This chart shows how the market values ββthis scalable model. Its high cost per employee is a result of the platform's ability to serve thousands of users simultaneously.
Market capitalization per employee (in thousands of dollars) in the market segment - Telemed
DarioHealth offers a digital platform for chronic disease management. In the digital health sector, market capitalization per employee is an indicator of scalability. A high figure indicates that its app is capable of serving a large number of users, generating revenue from subscriptions and partnerships.
Market capitalization per employee (in thousands of dollars) for the overall market
DarioHealth is a digital therapeutics company offering a platform for managing chronic conditions such as diabetes and hypertension. This chart shows how the market evaluates the company's ability to use technology and data to improve user health and reduce healthcare costs.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company DarioHealth Corp. (DRIO)
DarioHealth is a digital health company offering a SaaS platform for managing chronic diseases (diabetes, hypertension). It's a B2B2C business. This graph (likely negative) shows how much the company invests in development and, most importantly, sales, burning capital on each employee to close contracts.
Profit per employee (in thousands of dollars) in the market segment - Telemed
DarioHealth Corp. offers a digital therapeutic platform for managing chronic conditions such as diabetes and hypertension. This chart demonstrates the effectiveness of their digital healthcare model. It reflects how successfully the company monetizes its platform through subscriptions, helping patients and generating high profits through its team of developers and medical experts.
Profit per employee (in thousands of dollars) for the market as a whole
DarioHealth Corp. provides a digital therapeutics platform (Digital Therapeutics) for managing chronic diseases (diabetes, hypertension). It is a SaaS business in the healthcare industry. This chart shows how successfully the company is attracting paid users (B2B and B2C), scaling its platform to achieve high profitability per employee.
Sales to employees of the company, segment and market as a whole
Sales per company employee DarioHealth Corp. (DRIO)
DarioHealth is a digital health company offering a chronic disease management platform. This chart shows the effectiveness of its subscription model. The increase in revenue per employee reflects the growing number of users and the signing of contracts with corporate clients and insurers.
Sales per employee in the market segment - Telemed
DarioHealth (DRIO) is a digital therapeutics company offering a platform (glucometer, app) for managing chronic diseases such as diabetes and hypertension. This chart shows the average revenue per employee in the segment. Comparing DRIO to this benchmark demonstrates how effectively their platform and team generate revenue (primarily B2B) from their digital solutions.
Sales per employee for the market as a whole
DarioHealth (DRIO) offers a digital platform (SaaS) for chronic disease management. This metric is a test of their business model. It measures how successfully the company attracts and retains paying users (both B2C and B2B contracts) while monetizing their technology platform. Growth speaks to the scalability of their IT solutions.
Short shares by company, segment and market as a whole
Shares shorted by company DarioHealth Corp. (DRIO)
DarioHealth is a digital health company offering a platform (glucometer, app) for managing chronic diseases, primarily diabetes. This chart shows the odds that they will lose to the competition. The market is crowded with giants (Livongo, Dexcom), and the bears believe DarioHealth has no chance in this battle.
Shares shorted by market segment - Telemed
DarioHealth (DRIO) is a digital platform for managing chronic diseases (diabetes, hypertension). This chart highlights the pessimism in the sector. The growing short position in the industry is a bet that DRIO will be unable to monetize its software. Investors doubt that insurers and employers (DRIO's clients) will pay en masse for the app and expect it to burn through marketing dollars.
Shares shorted by the overall market
DarioHealth is a platform for managing chronic diseases (diabetes, hypertension). This chart shows the overall market pessimism. Investors fear that a recession will cause employers (Dario's clients) to cut budgets for wellness programs, preferring basic health insurance.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator DarioHealth Corp. (DRIO)
This oscillator for DarioHealth is an indicator of faith in digital treatment for chronic diseases. The company offers a platform for managing diabetes and hypertension. "Overbought" levels (above 70) arise on news of subscriber growth or large contracts with employers. High marketing costs and fierce competition in telemedicine lead to "oversold" levels.
RSI 14 Market Segment - Telemed
DarioHealth (DRIO) β "Health" on your phone (Israel). Their *platform* (SaaS + devices) is a *"digital therapist"* for *chronic* patients (diabetes, hypertension, musculoskeletal disorders). The "Telemedicine" sector is thriving on hype. RSI_14_Seg shows the "temperature" of the *entire* industry. It helps us understand: is DRIO's growth driven by their B2B model, or is the *entire* sector overheated?
RSI 14 for the overall market
DarioHealth (DRIO), a telemedicine platform. This chart is an indicator of hype and competition. During the euphoria (and the pandemic), investors were willing to fund the "future of medicine." In the panic, they see fierce competition and high marketing costs, calling into question the profitability of the business model.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast DRIO (DarioHealth Corp.)
DarioHealth (DRIO) is a digital therapeutics platform that helps users manage chronic conditions (diabetes, hypertension) through an app and coaching. This chart shows the average target price. It reflects analysts' expectations for growth in its B2B contracts (with employers and insurers).
The difference between the consensus estimate and the actual stock price DRIO (DarioHealth Corp.)
DarioHealth is a digital health company. Their platform (app and smart devices) helps people manage chronic conditions such as diabetes and hypertension. This chart shows the growth potential analysts see. It measures the gap between the price and forecast, reflecting their confidence in the company's B2B strategy of selling this subscription platform to large employers and insurers.
Analyst consensus forecast for stock prices by market segment - Telemed
DarioHealth is a "clinic in a smartphone." The company provides a SaaS platform that helps patients (and their employers) manage chronic conditions such as diabetes and hypertension. This chart reflects analysts' general expectations for the telemedicine sector. It shows whether experts believe the digital therapy market will grow.
Analysts' consensus forecast for the overall market share price
DarioHealth is a digital health (telemedicine) company providing a platform (software and devices) for managing chronic diseases such as diabetes. This chart shows the overall "risk appetite" in the market. For Dario, an unprofitable but growing HealthTech company, the overall optimism (the rising chart) is important for funding and investor confidence in its model.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index DarioHealth Corp.
DarioHealth is a digital clinic in your pocket. They provide a D2C platform (glucometer, app, coaches) for self-management of chronic diseases, primarily diabetes. This chart is a summary indicator of their D2C healthcare. It reflects their ability to attract (UA) and retain subscribers (churn) and their (difficult) path to profitability.
AKIMA Market Segment Index - Telemed
DarioHealth (DRIO) is a digital therapeutics company. Their AI-powered platform helps users manage chronic conditions such as diabetes, hypertension, and depression via smartphone. The chart shows the average index for the segment, helping investors assess how successfully DRIO is monetizing the telemedicine market compared to the average.
The AKIM Index for the overall market
DarioHealth is a digital therapy company offering solutions for managing chronic diseases (diabetes, hypertension) via smartphone. This chart, reflecting the market average, is just a backdrop. It helps assess how DRIO, which sells its services to insurers and employers, compares to overall macroeconomic trends.